Ophthalmic Devices Market Size, Share & Industry Analysis, By Product Type (Ophthalmic Surgical Devices, Ophthalmic Diagnostic Devices, and Vision Care Devices), By End-user (Hospitals, Ophthalmic Clinics, Others), and Regional Forecast, 2019-2026 (Includes COVID-19 Business Impact)

                                          
We have updated Ophthalmic Devices Market with respect to COVID-19 Business Impact.
Inquire before buying


This report focuses on the Ophthalmic Devices market and value at the global level, regional level, and company level. From a global perspective, this report represents the overall Ophthalmic Devices market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America.


Global Ophthalmic Devices Market: Segment Analysis


The research report includes specific segments by region (country), by Company, by Type, and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2029. An in-depth analysis of the segments assists in identifying the different factors that will aid market growth.


Global Ophthalmic Devices Market: Regional Analysis


The research report includes a detailed study of regions of North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America. The report has been curated after observing and studying various factors that determine regional growth such as the economic, environmental, social, technological, and political status of the particular region. Researchers have studied the data of revenue, sales, and manufacturers of each mentioned region. This section analyses region-wise revenue and volume for the forecast period of 2019 to 2029.


Global Ophthalmic Devices Market: Competitive Landscape


This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2019 to 2029.
List of Companies Profiled

Essilor and Alcon Together Hold the Largest Ophthalmic Devices Market Share
The dominating companies in the global ophthalmic device market include Essilor, Alcon, and Johnson and Johnson Services, Inc. These companies together hold more than 50% share in the global market. This is predominantly attributed to the increased focus on developing innovative products and emphasis on mergers, acquisitions and collaborations. In August 2019, Alcon launched AcrySofIQ PanOptix, the world first and only FDA approved trifocal intraocular lens in the U.S. Additionally, in the fiscal year 2017, Johnson and Johnson Vision, a division of Johnson and Johnson Services, Inc. completed the acquisition of Abbott Medical Optics. Such strategic moves could enable the companies to garner predominant ophthalmic devices market share in the coming years. Other compiles operating in the ophthalmic devices market include Bausch Health Companies, ZEISS International, HOYA, TOCON, CooperVision, among others.

List Of Key Companies Covered:

  
Alcon (Part of Novartis AG)
  
Johnson & Johnson Services, Inc.
  
Essilor
  
Bausch Health Companies
  
ZEISS International
  
HOYA
  
NIDEK CO., LTD
  
TOPCON
  
CooperVision
  
Other Prominent Players

 

REPORT COVERAGE

The report provides detailed information regarding various insights into the market. Some of them are growth drivers, restraints, competitive landscape, regional analysis, and challenges. It further offers an analytical depiction of the ophthalmic devices market trends and estimations to illustrate the forthcoming investment pockets. The market is quantitatively analyzed from 2019 to 2026 to provide the financial competency of the market. The information gathered in the report has been taken from several primary and secondary sources. The report can further help stakeholders to gain valuable insights into the ophthalmic devices market. The report offers a detailed competitive landscape by presenting information on key players, along with their strategies in the market.
The report presents a comprehensive assessment of the global ophthalmic devices market by offering valuable insights, facts, industry-related information, and historical data. These include key insights such as the pipeline analysis, introduction of new products/approvals (by major players), key industry developments - mergers, acquisitions, and partnerships, technological advancements in ophthalmic surgery, among others.

Report Scope & Segmentation

 Segmentation

By Product Type

Ophthalmic Surgical Devices

  
Cataract Surgery
  
Vitreoretinal Surgery
  
Refractive Error Surgery
  
Glaucoma Surgery

Ophthalmic Diagnostic Devices
Vision Care Devices

  
Contact lenses
  
Intraocular lenses

By End-user

  
Hospitals
  
Ophthalmic Clinics
  
Others

By Geography

  
North America (U.S. and Canada)
  
Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  
Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia- Pacific)
  
Latin America (Brazil, Mexico, and Rest of Latin America)
  
Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)

INDUSTRY DEVELOPMENTS:

April 2019: Novartis announced that Alcon will now operate as an independent company. Novartis and Alcon have been operating together in a collaboration since eight years.

December 2019: J&J Vision launched Tecnis Toric II intraocular lens in U.S. market

January 2019: Johnson & Johnson Vision announced the U.S. availability of ACUVUE OASYS with transitions light intelligent technology. The contact lenses seamlessly adapt to changing light, helping eyes recover from bright light up to five seconds faster, reducing halos and starbursts at night.

September 2019: Essilor launched the next generation fully automated Retinal Imaging System (RETINA800) fundus camera in the U.S market.